Rachana Singh, M.D.
Clinical Assistant Professor of Radiation Oncology
Capital Health Systems at Mercer
446 Bellevue Avenue
Trenton, NJ 08607
Phone: 609-394-4243
Fax: 609-394-4156
http://www.capitalhealth.org/main/oncology/index.asp
(affliated with University of Pennsylvania School of Medicine)
Education
- 1994 B.A. Cornell University (Chemistry)
- 1998 M.D. UMDNJ, Robert Wood Johnson Medical School
- 1998-99 Transitional Intern, Department of Medicine, Albert Einstein Medical Center
- 1999-03 Resident, Radiation and Cellular Oncology, University of Chicago Hospital
- 2001-03 Chief Resident, Radiation and Cellular Oncology, University of Chicago Hospital
Board Certifications
- American Board of Radiology, Radiation Oncology, 2003
Areas of Interest
My clinical focus is providing excellent comprehensive oncology care to our patients in the community. This involves working closely with our surgical and medical oncology colleagues at the University of Pennsylvania and in the Mercer county community to facilitate seamless multidisciplinary patient care. My personal interests include treating breast, gastrointestinal and gynecologic malignancies in a supportive outpatient environment.
Recent Publications
Singh, R., Al-Hallaq, H., Pelizzari, C.A., Zagaja, G.P., Chen, A., Jani, A.B.: Dosimetric quality endpoints for low-dose-rate prostate brachytherapy using biological effective dose (BED) vs. conventional dose. Med Dosim 28 (4): 255-259, 2003.
Singh, R. Comparing breast cancer behavior in women over 70 to younger woman: A natural history analysis. AJOR Suppl (1): 10-17, 2004.
Taneja, N., Davis, M., Choy, J.S., Beckett, M.A., Singh, R., Kron, S.J., Weichselbaum, R.R.: Histone H2Ax phosphorylation as a predictor of radiosensitivity and target for radiotherapy. Journal Biol Chem 279 (3): 2273-80, 2004.
Singh, R., Hellman, S., Heimann, R.: Breast cancer in the elderly: Implications for screening and treatment. CANCER 100 (9): 1807-1813, 2004.
Salama, J.K., Singh, R., Heimann, R.: Does the number of tumor free axillary lymph nodes impact on the outcome of node negative breast cancer patients? CANCER 103 (4): 664-671, 2005.
Kao, J., Conzen, S.D., Jaskowiak, N.T., Song, D.H., Recant, W., Singh, R., Masters, G.A., Fleming, G.F., Heimann, R.: Concomitant radiation therapy and paclitaxel for unresectable locally advanced metastatic breast cancer: Results from two consecutive phase I-II trials. International Journal of Radiation Oncology, Biology and Physics 15; 61 (4): 1045-53, 2005.
Professional Activities
- American Society for Therapeutic Radiology and Oncology
» TOP
© University of Pennsylvania | School of Medicine | University of Pennsylvania Health System